Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase NA 18Phase 1 9Phase 3 6Phase 1/2 6Phase EARLY_PHASE1 2

Status

Completed 24Terminated 12Unknown 6Recruiting 6Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 6

Sponsor

Cancer Type

Head & Neck 4Thoracic 1Dermatologic 1

Conditions

Breast Neoplasms 129Carcinoma, Non-Small-Cell Lung 101Prostatic Neoplasms 62Colorectal Neoplasms 49Nasopharyngeal Carcinoma 45Neoplasms 44Multiple Myeloma 42Stomach Neoplasms 35Neoplasm Metastasis 32Leukemia, Myeloid, Acute 32Ovarian Neoplasms 31Lung Neoplasms 31Carcinoma, Hepatocellular 29Squamous Cell Carcinoma of Head and Neck 27Rectal Neoplasms 27Pancreatic Neoplasms 26Triple Negative Breast Neoplasms 25Recurrence 25Small Cell Lung Carcinoma 21Brain Neoplasms 21Esophageal Neoplasms 20Colonic Neoplasms 20Uterine Cervical Neoplasms 19Lymphoma, Large B-Cell, Diffuse 17Head and Neck Neoplasms 17Urinary Bladder Neoplasms 16Leukemia, Lymphocytic, Chronic, B-Cell 16Esophageal Squamous Cell Carcinoma 16Carcinoma, Renal Cell 16Myasthenia Gravis 15

Interventions

Cetuximab 2pembrolizumab 1ficlatuzumab 1cemiplimab 1alpha-2'-deoxythioguanosine 1Vinorelbine 1Radiotherapy 1Niacinamide 1Gemcitabine 1Drug Therapy 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Carcinoma, Squamous Cell × Clear all
NCT04892173 2026-06-05

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Johnson & Johnson Enterprise Innovation Inc.

Phase 3 Recruiting
500 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT06064877 2026-04-09

FIERCE-HN

AVEO Pharmaceuticals, Inc.

Phase 3 Recruiting
410 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Neoplasm Metastasis, Recurrence

NCT06908304 2026-01-12

A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC

Maia Biotechnology

Phase 3 Recruiting
300 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

NCT05333523 2025-11-24

PRIMO

Radboud University Medical Center

Phase 3 Recruiting
242 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT05955924 2025-02-21

SPRINTR

Women's College Hospital

Phase 3 Recruiting
396 enrolled
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

NCT04747054 2024-10-26

PembroMetaRT

UNICANCER

Phase 3 Recruiting
102 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡